PHI with Diabetes with renal manifestation
How does this condition affect your private health insurance?
Diabetic nephropathy is a severe complication where high blood sugar progressively damages the kidney's filtering units. This impairs their ability to remove waste, leading to protein leakage (albuminuria) and a decline in kidney function. Initially silent, it can advance to chronic kidney disease and end-stage renal disease, requiring dialysis or transplantation. Uncontrolled diabetes and hypertension are primary drivers. Symptoms, like swelling or fatigue, often appear in later stages. It significantly increases the risk of cardiovascular disease and is a major cause of kidney failure worldwide.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Once clinically detectable (e.g., microalbuminuria), it signifies a chronic, progressive process that develops over years and continues lifelong.
Duration of Illness (Lifetime)
Chronic and progressive; typically a lifelong condition requiring continuous management, often advancing to end-stage renal disease.
Cost of Treatment (Initial)
Initial diagnostic workup and early management can range from several hundred to a few thousand Euros/Dollars, depending on the healthcare system and necessary tests.
Cost of Treatment (Lifetime)
Can be very high, ranging from tens of thousands to several hundred thousand Euros/Dollars, especially if it progresses to dialysis or kidney transplantation.
Mortality Rate
Significantly increased, particularly due to associated cardiovascular complications and progression to end-stage renal disease, which has a high mortality rate.
Risk of Secondary Damages
Very high. Common secondary damages include cardiovascular disease (heart attack, stroke), anemia, bone disorders, neuropathy, retinopathy, and increased infection risk. Psychological impact is also considerable.
Probability of Full Recovery
Very low. While early and aggressive management can slow progression or even achieve remission of microalbuminuria, complete recovery without any long-term consequences is rare once the disease is established.
Underlying Disease Risk
Very high. Diabetes mellitus is the underlying cause. Common comorbidities include hypertension (high blood pressure), dyslipidemia (abnormal cholesterol levels), and other cardiovascular diseases.